Low DBP may not be an independent risk for cardiovascular death in revascularized coronary artery disease patients
- PMID: 21857536
- DOI: 10.1097/HJH.0b013e32834a5a67
Low DBP may not be an independent risk for cardiovascular death in revascularized coronary artery disease patients
Abstract
Objectives: It remains controversial whether extremely low DBP is a risk for cardiovascular events in patients with coronary artery disease (CAD). Coronary revascularization therapy became prevalent in CAD patients. We sought to determine the impact of low DBP on cardiovascular events and to investigate the predicting factors in revascularized CAD patients.
Methods: We subanalyzed 7180 stable, chronic CAD patients (median follow-up period 3.6 years) of 9877 patients undergoing first coronary artery bypass graft or percutaneous coronary intervention in the registry of the Coronary REvascularization Demonstrating Outcome study in Kyoto (CREDO-Kyoto).
Results: Kaplan-Meier analysis revealed that unadjusted cumulative incidence of cardiovascular death was greater in patients with preprocedural DBP of less than 70 mmHg than in those with DBP of at least 70 mmHg, whereas the cumulative incidences of nonfatal myocardial infarction (MI) and of stroke were similar between the two groups. Stepwise logistic regression analysis showed that estimated glomerular filtration ratio (inversely), pulse pressure, left ventricular ejection fraction of less than 0.40, history of heart failure, prior cerebrovascular disease, and prior MI were independent risks for cardiovascular death in patients with DBP of less than 70 mmHg. After adjustments for the independent risks, the cumulative hazard ratio for cardiovascular death did not differ between patients with DBP of less than 70 mmHg and those with DBP of at least 70 mmHg.
Conclusion: Renal insufficiency, more advanced vascular damage, and left ventricular systolic dysfunction were significant factors accounting for increased cardiovascular death in revascularized CAD patients with DBP of less than 70 mmHg. It was suggested that after adjustments for these independent risks, low DBP may not be a significant risk for cardiovascular death in revascularized CAD patients.
Comment in
-
J-curve for DBP and cardiovascular mortality in coronary artery disease patients: myth or reality.J Hypertens. 2011 Oct;29(10):1854-6. doi: 10.1097/HJH.0b013e32834b62a3. J Hypertens. 2011. PMID: 21904151 No abstract available.
Similar articles
-
Impact of Low Diastolic Blood Pressure on Risk of Cardiovascular Death in Elderly Patients With Coronary Artery Disease After Revascularization - The CREDO-Kyoto Registry Cohort-1.Circ J. 2016 Apr 25;80(5):1232-41. doi: 10.1253/circj.CJ-15-1151. Epub 2016 Apr 6. Circ J. 2016. PMID: 27053493
-
Impact of polyvascular disease on clinical outcomes in patients undergoing coronary revascularization: an observation from the CREDO-Kyoto Registry Cohort-2.Atherosclerosis. 2013 Jun;228(2):426-31. doi: 10.1016/j.atherosclerosis.2013.04.005. Epub 2013 Apr 18. Atherosclerosis. 2013. PMID: 23623262
-
Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.Cardiovasc Revasc Med. 2009 Jul-Sep;10(3):144-50. doi: 10.1016/j.carrev.2009.01.005. Cardiovasc Revasc Med. 2009. PMID: 19595394
-
Balancing benefit against risk in the choice of therapy for coronary artery disease. Lesson from prospective, randomized, clinical trials of percutaneous coronary intervention and coronary artery bypass graft surgery.Minerva Cardioangiol. 2003 Oct;51(5):585-97. Minerva Cardioangiol. 2003. PMID: 14551526 Review.
-
Controversies in cardiovascular medicine: Chronic stable coronary artery disease: drugs vs. revascularization.Eur Heart J. 2010 Mar;31(5):530-41. doi: 10.1093/eurheartj/ehp605. Epub 2010 Jan 26. Eur Heart J. 2010. PMID: 20106842 Review.
Cited by
-
Blood pressure targets in the treatment of high blood pressure: a reappraisal of the J-shaped phenomenon.J Hum Hypertens. 2014 Feb;28(2):80-4. doi: 10.1038/jhh.2013.78. Epub 2013 Aug 22. J Hum Hypertens. 2014. PMID: 23966174 Review.
-
Prevention of atherosclerotic cerebro-cardiovascular disease: a key objective in blood pressure management for coronary artery disease in East Asia.Hypertens Res. 2025 Feb;48(2):830-832. doi: 10.1038/s41440-024-01966-3. Epub 2024 Oct 30. Hypertens Res. 2025. PMID: 39478192
-
Intensive blood pressure-lowering treatment to prevent cardiovascular events in patients with diabetes: a systematic review and meta-analysis.Hypertens Res. 2025 Jul;48(7):2024-2033. doi: 10.1038/s41440-025-02209-9. Epub 2025 Apr 23. Hypertens Res. 2025. PMID: 40269228
-
Blood pressure management in patients with type 2 diabetes mellitus.Hypertens Res. 2017 Aug;40(8):721-729. doi: 10.1038/hr.2017.55. Epub 2017 Apr 27. Hypertens Res. 2017. PMID: 28446809 Review.
-
[J curve: when lowering blood pressure becomes a hazard?].Internist (Berl). 2013 Mar;54(3):376-82. doi: 10.1007/s00108-012-3232-1. Internist (Berl). 2013. PMID: 23404268 German.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous